The Indian hospital industry accounting for 80% of the total healthcare market is expected to touch US$ 132 billion by 2023
US$ 372 bn
Expected valuation of Indian healthcare sector by the end of 2022
US$ 11.28 billion
allocated to the Ministry of Health and Family Welfare (MoHFW) in Budget 2022
2.1% of GDP
Public expenditure on healthcare
US$ 13.42 bn
Projected valuation of Indian medical tourism market by 2026
Ayushman Bharat
aims to provide annual healthcare coverage of nearly US$7,000 per family, benefiting more than 500 million vulnerable people.
33.33%
share in the total gross written premiums earned in the country
US$ 4.32 billion
M&A activity for the healthcare and pharmaceutical sector in India in the first half of 2022
93 lakh
number of policies issued to women in FY21
US$ 19.41 bn
FDI inflows for the drugs and pharmaceuticals sector between April 2000-March 2022
+91-11-23379651
+91 124 4382629
+91-22-28741366
+91-11-23370009, +91-9999116375
India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive and capital establishments
American drugmaker Merck operates a manufacturing plant in India.
French drugmaker Sanofi operates a manufacturing plant in Goa.
UK's GlaxoSmithKline operates R&D and manufacturing in India.
Singapore's 4CE Ventures has invested in Indian health tech startups.
India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive, and capital establishments
India has 81,000 government-recognized startups across 656 districts, making it …
Read MoreAlmost 60% of all the vaccines for the coronavirus used …
Read MoreIndia’s ‘bio economy’ has grown eight times in the last …
Read More